glp-1 weight loss non diabetic The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials A Balancing Act: GLP-1 Receptor
Description
This review walks you through how it works, what it costs, and whether Ros weight-loss program lives up to the hype
The data revealed that only 1 in 4 patients who started taking a GLP-1 for weight loss was taking the drug a year later
Search strategy We created a search syntax for 3 databases
Consent for Publication All authors have reviewed and approved the final manuscript for publication
Finally, a pooled analysis of RCTs and open-label phase III studies showed that once-weekly exenatide reduced albuminuria 26% (95% CI%: 39.5 to 10%) compared with comparators (Van Der Aart-Van Der Beek et al., 2020)
